Item Type | Name |
Academic Article
|
A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease.
|
Academic Article
|
RNA oxidation in Alzheimer disease and related neurodegenerative disorders.
|
Academic Article
|
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.
|
Academic Article
|
Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.
|
Academic Article
|
Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease.
|
Academic Article
|
Insulin is a two-edged knife on the brain.
|
Academic Article
|
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta.
|
Academic Article
|
Commentary: "Ceramide and cholesterol: possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?" by Claudio Costantini, Rekha M.K. Kolasani, and Luigi Puglielli.
|
Academic Article
|
Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy?
|
Academic Article
|
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.
|
Academic Article
|
Mitochondria: a therapeutic target in neurodegeneration.
|
Academic Article
|
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.
|
Academic Article
|
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.
|
Academic Article
|
Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.
|
Academic Article
|
Novel therapeutics for Alzheimer's disease: an update.
|
Academic Article
|
Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
|
Academic Article
|
A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.
|
Academic Article
|
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease.
|
Academic Article
|
Mark Anthony Smith (1965-2010): Visionary, Alzheimer researcher, and editor-in-chief of the Journal of Alzheimer's Disease.
|
Academic Article
|
Iron: A Pathological Mediator of Alzheimer Disease?
|
Academic Article
|
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.
|
Academic Article
|
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention.
|
Academic Article
|
Mark A. Smith: the scientist, the man.
|
Academic Article
|
Signaling effect of amyloid-beta(42) on the processing of AbetaPP.
|
Academic Article
|
Abnormal mitochondrial dynamics and neurodegenerative diseases.
|
Academic Article
|
Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.
|
Academic Article
|
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.
|
Academic Article
|
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
|
Academic Article
|
Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease.
|
Academic Article
|
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.
|
Academic Article
|
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
|
Academic Article
|
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.
|
Academic Article
|
Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease.
|
Academic Article
|
Widespread distribution of reticulon-3 in various neurodegenerative diseases.
|
Academic Article
|
Biomarkers in Alzheimer's disease: past, present and future.
|
Academic Article
|
Oxidative stress in Alzheimer disease: a possibility for prevention.
|
Academic Article
|
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
|
Academic Article
|
Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.
|
Academic Article
|
Antioxidant approaches for the treatment of Alzheimer's disease.
|
Academic Article
|
Autophagy in Alzheimer's disease.
|
Academic Article
|
AGEs/RAGE complex upregulates BACE1 via NF-?B pathway activation.
|
Academic Article
|
Mitochondrial Drugs for Alzheimer Disease.
|
Academic Article
|
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
|
Academic Article
|
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.
|
Academic Article
|
Treatment advances in Alzheimer's disease based on the oxidative stress model.
|
Academic Article
|
Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?
|
Academic Article
|
Role of metal dyshomeostasis in Alzheimer's disease.
|
Academic Article
|
Modeling cholesterol metabolism by gene expression profiling in the hippocampus.
|
Academic Article
|
Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease.
|
Academic Article
|
Frontiers in Alzheimer's disease therapeutics.
|
Academic Article
|
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease.
|
Academic Article
|
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Amyloid-? peptide structure in aqueous solution varies with fragment size.
|
Academic Article
|
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.
|
Academic Article
|
Nuclear and mitochondrial DNA oxidation in Alzheimer's disease.
|
Academic Article
|
Untangling the vascular web from Alzheimer disease and oxidative stress.
|
Academic Article
|
Alzheimer's disease and vascular deficiency: lessons from imaging studies and down syndrome.
|
Academic Article
|
The role of iron as a mediator of oxidative stress in Alzheimer disease.
|
Academic Article
|
Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest.
|
Academic Article
|
The contribution of the amyloid hypothesis to the understanding of Alzheimer's disease: a critical overview.
|
Academic Article
|
The impairment of insulin signaling in Alzheimer's disease.
|
Academic Article
|
Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease.
|
Academic Article
|
The structures of the E22? mutant-type amyloid-? alloforms and the impact of E22? mutation on the structures of the wild-type amyloid-? alloforms.
|
Academic Article
|
Amyloid ? peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system.
|
Academic Article
|
Modification of amyloid-?1-42 fibril structure by methionine-35 oxidation.
|
Academic Article
|
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules.
|
Academic Article
|
Intrahippocampal amyloid-? (1-40) injections injure medial septal neurons in rats.
|
Academic Article
|
Mark A. Smith, 1965-2010: consummate student of pathogenesis.
|
Academic Article
|
Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!
|
Academic Article
|
Mark A. Smith: neurocytochemistry innovator.
|
Academic Article
|
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.
|
Academic Article
|
Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.
|
Academic Article
|
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?
|
Academic Article
|
Iron chelation and nanoparticle target delivery in the development of new multifunctional disease-modifying drugs for Alzheimer's disease.
|
Academic Article
|
Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease.
|
Academic Article
|
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
|
Academic Article
|
Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress.
|
Academic Article
|
Preface. Alzheimer's disease: advances for a new century.
|
Academic Article
|
DNA damage in Alzheimer disease lymphocytes and its relation to premature centromere division.
|
Academic Article
|
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance.
|
Academic Article
|
Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease.
|
Academic Article
|
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.
|
Academic Article
|
Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease.
|
Academic Article
|
Ethics review as a catalyst for progress.
|
Academic Article
|
Differential network analyses of Alzheimer's disease identify early events in Alzheimer's disease pathology.
|
Academic Article
|
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
|
Academic Article
|
Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
|
Academic Article
|
Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview.
|
Academic Article
|
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-? and Phosphorylated Tau.
|
Academic Article
|
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.
|
Academic Article
|
Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease?
|
Academic Article
|
Antimicrobial peptide ?-defensin-1 expression is upregulated in Alzheimer's brain.
|
Academic Article
|
The complexities of the pathology-pathogenesis relationship in Alzheimer disease.
|
Academic Article
|
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.
|
Academic Article
|
Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.
|
Academic Article
|
From Neurodegeneration to Brain Health: An Integrated Approach.
|
Academic Article
|
Simultaneous onset of Alzheimer's disease in a husband and wife in their mid-fifties: what do we really know about environmental factors?
|
Academic Article
|
Posttranslational modifications of a-tubulin in alzheimer disease.
|
Academic Article
|
Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
|
Academic Article
|
Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease.
|
Academic Article
|
Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
|
Academic Article
|
Molecular Mapping Alzheimer's Disease: MALDI Imaging of Formalin-fixed, Paraffin-embedded Human Hippocampal Tissue.
|
Academic Article
|
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.
|
Academic Article
|
Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains.
|
Academic Article
|
Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease.
|
Academic Article
|
Estrogen receptor-a is localized to neurofibrillary tangles in Alzheimer's disease.
|
Academic Article
|
Fibrillar Amyloid-? Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3?Tg-AD Transgenic Mouse.
|
Academic Article
|
Meta-analysis of Telomere Length in Alzheimer's Disease.
|
Academic Article
|
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease.
|
Academic Article
|
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
|
Academic Article
|
Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to ? sheet in tau protein linked to Alzheimer's disease.
|
Academic Article
|
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model.
|
Academic Article
|
Thermodynamics of Amyloid-? Fibril Elongation: Atomistic Details of the Transition State.
|
Academic Article
|
Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens.
|
Academic Article
|
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-? Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
|
Academic Article
|
Precision pharmacology for Alzheimer's disease.
|
Academic Article
|
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
|
Academic Article
|
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry.
|
Academic Article
|
The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease.
|
Academic Article
|
TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
|
Academic Article
|
Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS.
|
Academic Article
|
Iron?ic facts about dementia.
|
Academic Article
|
Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex.
|
Academic Article
|
Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
|
Academic Article
|
Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
|
Academic Article
|
Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
|
Academic Article
|
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study.
|
Academic Article
|
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
|
Academic Article
|
The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation.
|
Academic Article
|
Differences in structure and function between human and murine tau.
|
Academic Article
|
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.
|
Academic Article
|
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
|
Academic Article
|
Polyphenols in Alzheimer's Disease and in the Gut-Brain Axis.
|
Academic Article
|
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
|
Academic Article
|
The Microbiota-Gut-Brain Axis-Heart Shunt Part II: Prosaic Foods and the Brain-Heart Connection in Alzheimer Disease.
|
Academic Article
|
Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.
|
Academic Article
|
Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
|
Academic Article
|
High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal.
|
Academic Article
|
The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
|
Academic Article
|
Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?
|
Academic Article
|
Predicting the failure of amyloid-beta vaccine.
|
Academic Article
|
Dangers of the amyloid-beta vaccination.
|
Academic Article
|
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis.
|
Academic Article
|
Ill-fated amyloid-beta vaccine.
|
Academic Article
|
The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease.
|
Academic Article
|
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
|
Academic Article
|
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?
|
Academic Article
|
Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response.
|
Academic Article
|
Amyloid-beta: a (life) preserver for the brain.
|
Academic Article
|
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.
|
Academic Article
|
Alzheimer Disease and Oxidative Stress.
|
Academic Article
|
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.
|
Academic Article
|
The role of mitogen-activated protein kinase pathways in Alzheimer's disease.
|
Academic Article
|
Differential regulation of glutamate receptors in Alzheimer's disease.
|
Academic Article
|
Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease.
|
Academic Article
|
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
|
Academic Article
|
Distribution, levels, and activation of MEK1 in Alzheimer's disease.
|
Academic Article
|
Involvement of Maillard reactions in Alzheimer disease.
|
Academic Article
|
Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.
|
Academic Article
|
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
|
Academic Article
|
A metabolic basis for Alzheimer disease.
|
Academic Article
|
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways.
|
Academic Article
|
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients.
|
Academic Article
|
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
|
Academic Article
|
Alzheimer's disease: the two-hit hypothesis.
|
Academic Article
|
Oxidative stress signalling in Alzheimer's disease.
|
Academic Article
|
Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.
|
Academic Article
|
Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?
|
Academic Article
|
The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease.
|
Academic Article
|
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.
|
Academic Article
|
The "Down's" side of mitochondria.
|
Academic Article
|
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins.
|
Academic Article
|
Call for Elan to publish Alzheimer's trial details.
|
Academic Article
|
The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
|
Academic Article
|
Causes and consequences of oxidative stress in Alzheimer's disease.
|
Academic Article
|
Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease.
|
Academic Article
|
Is Alzheimer's disease a mitochondrial disorder?
|
Academic Article
|
Amyloid-beta: a vascular sealant that protects against hemorrhage?
|
Academic Article
|
Role of mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology.
|
Academic Article
|
Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.
|
Academic Article
|
Iron: a pathological mediator of Alzheimer disease?
|
Academic Article
|
Estrogen replacement and risk of Alzheimer disease.
|
Academic Article
|
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.
|
Academic Article
|
Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out?
|
Academic Article
|
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
|
Academic Article
|
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.
|
Academic Article
|
Possible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease.
|
Academic Article
|
Increased p27, an essential component of cell cycle control, in Alzheimer's disease.
|
Academic Article
|
Hydroxynonenal, toxic carbonyls, and Alzheimer disease.
|
Academic Article
|
Oxidative damage in the olfactory system in Alzheimer's disease.
|
Academic Article
|
Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease.
|
Academic Article
|
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
|
Academic Article
|
Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
|
Academic Article
|
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
|
Academic Article
|
Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
|
Academic Article
|
Perspectives on the amyloid-beta cascade hypothesis.
|
Academic Article
|
Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.
|
Academic Article
|
Oxidative stress and redox-active iron in Alzheimer's disease.
|
Academic Article
|
Homocysteine and Alzheimer's disease: a modifiable risk?
|
Academic Article
|
Neuroprotective properties of Bcl-w in Alzheimer disease.
|
Academic Article
|
Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
|
Academic Article
|
Prion disease and Alzheimer's disease: pathogenic overlap.
|
Academic Article
|
Tau phosphorylation and assembly.
|
Academic Article
|
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease.
|
Academic Article
|
The role of metabotropic glutamate receptors in Alzheimer's disease.
|
Academic Article
|
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection.
|
Academic Article
|
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
|
Academic Article
|
Tau modifiers as therapeutic targets for Alzheimer's disease.
|
Academic Article
|
Mitochondrial failures in Alzheimer's disease.
|
Academic Article
|
Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
|
Academic Article
|
Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
|
Academic Article
|
Carnosine: a versatile antioxidant and antiglycating agent.
|
Academic Article
|
Therapeutic opportunities in Alzheimer disease: one for all or all for one?
|
Academic Article
|
Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
|
Academic Article
|
The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
|
Academic Article
|
Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis.
|
Academic Article
|
Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.
|
Academic Article
|
A second look into the oxidant mechanisms in Alzheimer's disease.
|
Academic Article
|
Ferric cycle activity and Alzheimer disease.
|
Academic Article
|
Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells.
|
Academic Article
|
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target.
|
Academic Article
|
Amyloid beta: the alternate hypothesis.
|
Academic Article
|
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream.
|
Academic Article
|
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
|
Academic Article
|
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
|
Academic Article
|
Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease.
|
Academic Article
|
Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
|
Academic Article
|
Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!
|
Academic Article
|
Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
|
Academic Article
|
Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.
|
Academic Article
|
Solving the insoluble.
|
Academic Article
|
Alzheimer disease, the two-hit hypothesis: an update.
|
Academic Article
|
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
|
Academic Article
|
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.
|
Academic Article
|
c-Jun phosphorylation in Alzheimer disease.
|
Academic Article
|
Treating the lesions, not the disease.
|
Academic Article
|
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease.
|
Academic Article
|
Staying connected: synapses in Alzheimer disease.
|
Academic Article
|
Drug therapy in Alzheimer's disease.
|
Academic Article
|
Chronological primacy of oxidative stress in Alzheimer disease.
|
Academic Article
|
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.
|
Academic Article
|
Insulin signaling, diabetes mellitus and risk of Alzheimer disease.
|
Academic Article
|
Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
|
Academic Article
|
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
|
Academic Article
|
Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.
|
Academic Article
|
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
|
Academic Article
|
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease.
|
Academic Article
|
Oxidative imbalance in Alzheimer's disease.
|
Academic Article
|
Assembly in vitro of tau protein and its implications in Alzheimer's disease.
|
Academic Article
|
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis.
|
Academic Article
|
Oxidative stress and neurodegeneration.
|
Academic Article
|
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
|
Academic Article
|
Alzheimer's disease: an intracellular movement disorder?
|
Academic Article
|
Metal ions and oxidative protein modification in neurological disease.
|
Academic Article
|
Oxidative stress: the old enemy in Alzheimer's disease pathophysiology.
|
Academic Article
|
Chitin-like polysaccharides in Alzheimer's disease brains.
|
Academic Article
|
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease.
|
Academic Article
|
Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice".
|
Academic Article
|
The fallacy of amyloid and cognition in Alzheimer's disease.
|
Academic Article
|
Compensatory responses induced by oxidative stress in Alzheimer disease.
|
Academic Article
|
Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.
|
Academic Article
|
Therapeutic options in Alzheimer's disease.
|
Academic Article
|
Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
|
Academic Article
|
Involvement of oxidative stress in Alzheimer disease.
|
Academic Article
|
Increased expression of p130 in Alzheimer disease.
|
Academic Article
|
Apoptosis in Alzheimer disease: a mathematical improbability.
|
Academic Article
|
Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease.
|
Academic Article
|
Heme deficiency in Alzheimer's disease: a possible connection to porphyria.
|
Academic Article
|
Targeting gonadotropins: an alternative option for Alzheimer disease treatment.
|
Academic Article
|
Gonadotropins: a cohesive gender-based etiology of Alzheimer disease.
|
Academic Article
|
Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease.
|
Academic Article
|
Prevention and treatment of Alzheimer disease and aging: antioxidants.
|
Academic Article
|
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.
|
Academic Article
|
Vascular oxidative stress in Alzheimer disease.
|
Academic Article
|
Indices of metabolic dysfunction and oxidative stress.
|
Academic Article
|
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
|
Academic Article
|
Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
|
Academic Article
|
Oxidative stress and neurotoxicity.
|
Academic Article
|
The contribution of luteinizing hormone to Alzheimer disease pathogenesis.
|
Academic Article
|
Nucleic acid oxidation in Alzheimer disease.
|
Academic Article
|
Alzheimer disease and the role of free radicals in the pathogenesis of the disease.
|
Academic Article
|
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.
|
Academic Article
|
Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
|
Academic Article
|
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies.
|
Academic Article
|
Alzheimer disease pathology as a host response.
|
Academic Article
|
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material.
|
Academic Article
|
Phosphorylated tau: toxic, protective, or none of the above.
|
Academic Article
|
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.
|
Academic Article
|
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease.
|
Academic Article
|
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.
|
Academic Article
|
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
|
Academic Article
|
Getting the iron out: phlebotomy for Alzheimer's disease?
|
Academic Article
|
The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha.
|
Academic Article
|
Leptin: a novel therapeutic strategy for Alzheimer's disease.
|
Academic Article
|
Oxidative stress in diabetes and Alzheimer's disease.
|
Academic Article
|
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches.
|
Academic Article
|
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes.
|
Academic Article
|
Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.
|
Academic Article
|
Tau--an inhibitor of deacetylase HDAC6 function.
|
Academic Article
|
Commentary on "Perspective on a pathogenesis and treatment of Alzheimer's disease." Therapeutic strategies for Alzheimer's disease: the need for a new era of innovation.
|
Academic Article
|
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
|
Academic Article
|
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.
|
Academic Article
|
Iron: the Redox-active center of oxidative stress in Alzheimer disease.
|
Academic Article
|
Signal transduction cascades associated with oxidative stress in Alzheimer's disease.
|
Academic Article
|
Autophagocytosis of mitochondria is prominent in Alzheimer disease.
|
Academic Article
|
Increased autophagic degradation of mitochondria in Alzheimer disease.
|
Academic Article
|
Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts.
|
Academic Article
|
The role of novel chitin-like polysaccharides in Alzheimer disease.
|
Academic Article
|
Evidence for the role of luteinizing hormone in Alzheimer disease.
|
Academic Article
|
Current approaches in the treatment of Alzheimer's disease.
|
Academic Article
|
Menopause, estrogen, and gonadotropins in Alzheimer's disease.
|
Academic Article
|
Antioxidant therapy in Alzheimer's disease: theory and practice.
|
Academic Article
|
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8).
|
Concept
|
Alzheimer Disease
|
Academic Article
|
What is aging? What is its role in Alzheimer's disease? What can we do about it?
|
Academic Article
|
Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer's disease.
|
Academic Article
|
Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease.
|
Academic Article
|
Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients.
|
Academic Article
|
PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.
|
Academic Article
|
Microbes and Alzheimer's Disease.
|
Academic Article
|
Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting A? by Using Several Synthetic and Herbal Compounds.
|
Academic Article
|
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.
|
Academic Article
|
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
|
Academic Article
|
Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology.
|
Academic Article
|
Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease.
|
Academic Article
|
Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle.
|
Academic Article
|
Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.
|
Academic Article
|
Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.
|
Academic Article
|
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
|
Academic Article
|
Role of antioxidants and a nutrient rich diet in Alzheimer's disease.
|
Academic Article
|
National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in M?xico.
|
Academic Article
|
Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk.
|
Academic Article
|
Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.
|
Academic Article
|
Deconstructing mitochondrial dysfunction in Alzheimer disease.
|
Academic Article
|
The Alzheimer Precision Medicine Initiative.
|
Academic Article
|
Status and future directions of clinical trials in Alzheimer's disease.
|
Academic Article
|
Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution.
|
Academic Article
|
Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities.
|
Academic Article
|
Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.
|
Academic Article
|
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
|
Academic Article
|
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
|
Academic Article
|
Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
|
Academic Article
|
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases.
|
Academic Article
|
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
|
Academic Article
|
Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.
|
Academic Article
|
Electron microscopic localization of Alzheimer neurofibrillary tangle components recognized by an antiserum to paired helical filaments.
|
Academic Article
|
Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles.
|
Academic Article
|
Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease.
|
Academic Article
|
Immunoaffinity demonstration that paired helical filaments of Alzheimer disease share epitopes with neurofilaments, MAP2 and tau.
|
Academic Article
|
Tau-reactive neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's disease.
|
Academic Article
|
Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.
|
Academic Article
|
Immunolocalization of the amyloid precursor protein within the senile plaque.
|
Academic Article
|
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases.
|
Academic Article
|
Amyloid precursor protein in senile plaques of Alzheimer disease.
|
Academic Article
|
The amyloid percursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types.
|
Academic Article
|
Influence of neuronal location on antigenic properties of neurofibrillary tangles.
|
Academic Article
|
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.
|
Academic Article
|
Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
|
Academic Article
|
Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease.
|
Academic Article
|
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer disease.
|
Academic Article
|
Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease.
|
Academic Article
|
Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease.
|
Academic Article
|
Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
|
Academic Article
|
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease.
|
Academic Article
|
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton.
|
Academic Article
|
The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.
|
Academic Article
|
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
|
Academic Article
|
Neurochemistry of dementia: establishing the links.
|
Academic Article
|
Amyloid precursor protein in cell cultures: a 130 kDa polypeptide.
|
Academic Article
|
Alteration of neuritic cytoarchitecture in Alzheimer disease.
|
Academic Article
|
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
|
Academic Article
|
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
|
Academic Article
|
Hirano bodies contain tau protein.
|
Academic Article
|
Antibodies to the neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions.
|
Academic Article
|
Immunocytochemical properties of Alzheimer straight filaments.
|
Academic Article
|
Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease.
|
Academic Article
|
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.
|
Academic Article
|
Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease.
|
Academic Article
|
Ultrastructural localization of heme oxygenase-1 to the neurofibrillary pathology of Alzheimer disease.
|
Academic Article
|
Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains.
|
Academic Article
|
Early AGEing and Alzheimer's.
|
Academic Article
|
Alzheimer's disease and prion proteins: a meeting made in muscle.
|
Academic Article
|
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
|
Academic Article
|
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.
|
Academic Article
|
Aberrant phosphoinositide metabolism in Alzheimer's disease.
|
Academic Article
|
Alpha 1-trypsin immunoreactivity in Alzheimer disease.
|
Academic Article
|
Amyloidosis, advanced glycation end products and Alzheimer disease.
|
Academic Article
|
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease.
|
Academic Article
|
Evidence for oxidative stress in Pick disease and corticobasal degeneration.
|
Academic Article
|
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
|
Academic Article
|
APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology.
|
Academic Article
|
Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice.
|
Academic Article
|
Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress.
|
Academic Article
|
alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease.
|
Academic Article
|
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.
|
Academic Article
|
Free radical damage, iron, and Alzheimer's disease.
|
Academic Article
|
Trypsin interaction with the senile plaques of Alzheimer disease is mediated by beta-protein precursor.
|
Academic Article
|
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
|
Academic Article
|
Widespread peroxynitrite-mediated damage in Alzheimer's disease.
|
Academic Article
|
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
|
Academic Article
|
Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions.
|
Academic Article
|
Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
|
Academic Article
|
Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease.
|
Academic Article
|
Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease.
|
Academic Article
|
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
|
Academic Article
|
Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles.
|
Academic Article
|
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease.
|
Academic Article
|
Radical AGEing in Alzheimer's disease.
|
Academic Article
|
Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.
|
Academic Article
|
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
|
Academic Article
|
Alzheimer disease: an imbalance of proteolytic regulation?
|
Academic Article
|
beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.
|
Academic Article
|
Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles.
|
Academic Article
|
Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease.
|
Academic Article
|
Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link.
|
Academic Article
|
Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.
|
Academic Article
|
Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles.
|
Academic Article
|
Early contribution of oxidative glycation in Alzheimer disease.
|
Academic Article
|
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.
|
Academic Article
|
Is amyloid beta-protein glycated in Alzheimer's disease?
|
Academic Article
|
Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.
|
Academic Article
|
Alzheimer disease: protein-protein interaction and oxidative stress.
|
Academic Article
|
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.
|
Academic Article
|
Abnormal localization of iron regulatory protein in Alzheimer's disease.
|
Academic Article
|
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.
|
Academic Article
|
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.
|
Academic Article
|
Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine.
|
Academic Article
|
Altered glycosylation pattern of proteins in Alzheimer disease.
|
Academic Article
|
Striation is the characteristic neuritic abnormality in Alzheimer disease.
|
Academic Article
|
Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease.
|
Academic Article
|
Apoptosis and Alzheimer's disease.
|
Academic Article
|
[Is the lesion produced by oxidation a central part in the pathogenesis of Alzheimer's disease?].
|
Academic Article
|
CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains.
|
Academic Article
|
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.
|
Academic Article
|
Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.
|
Academic Article
|
Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model.
|
Academic Article
|
Amyloid-beta junkies.
|
Academic Article
|
Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease.
|
Academic Article
|
How important is oxidative damage? Lessons from Alzheimer's disease.
|
Academic Article
|
In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
|
Academic Article
|
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?
|
Academic Article
|
Copernicus revisited: amyloid beta in Alzheimer's disease.
|
Academic Article
|
Arson. Tracking the culprit in Alzheimer's disease.
|
Academic Article
|
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
|
Academic Article
|
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
|
Academic Article
|
Protein disulfide isomerase in Alzheimer disease.
|
Academic Article
|
Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease.
|
Academic Article
|
Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices.
|
Academic Article
|
Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a "foreign body".
|
Academic Article
|
Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
|
Academic Article
|
Protocol for quantitative analysis of paired helical filament solubilization: a method applicable to insoluble amyloids and inclusion bodies.
|
Academic Article
|
Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease.
|
Academic Article
|
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.
|
Academic Article
|
Is oxidative damage central to the pathogenesis of Alzheimer disease?
|
Academic Article
|
A suicide note from Alzheimer disease neurons?
|
Academic Article
|
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.
|
Academic Article
|
Universal isolation of cross-linked peptides: application to neurofibrillary tangles.
|
Academic Article
|
What are the facts and artifacts of the pathogenesis and etiology of Alzheimer disease?
|
Academic Article
|
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.
|
Academic Article
|
Genetic evidence for oxidative stress in Alzheimer's disease.
|
Academic Article
|
Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
|
Academic Article
|
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.
|
Academic Article
|
Alexander disease: Alzheimer disease of the developing brain?
|
Academic Article
|
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
|
Academic Article
|
Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
|
Academic Article
|
Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau.
|
Academic Article
|
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.
|
Academic Article
|
Oxidative damage in Alzheimer's disease: the metabolic dimension.
|
Academic Article
|
Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease.
|
Academic Article
|
Histochemical and immunocytochemical approaches to the study of oxidative stress.
|
Academic Article
|
Oxidative stress, antioxidants, and Alzheimer disease.
|
Academic Article
|
Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease.
|
Academic Article
|
Activation of NADPH oxidase in Alzheimer's disease brains.
|
Academic Article
|
The role of metals in neurodegenerative diseases.
|
Academic Article
|
Lipoperoxidation is selectively involved in progressive supranuclear palsy.
|
Academic Article
|
Oxidative stress in Alzheimer's disease.
|
Academic Article
|
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
|
Academic Article
|
Do neurons have a choice in death?
|
Academic Article
|
Mitochondrial abnormalities in Alzheimer's disease.
|
Academic Article
|
Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease.
|
Academic Article
|
Abortive apoptosis in Alzheimer's disease.
|
Academic Article
|
Chemistry and biochemistry of oxidative stress in neurodegenerative disease.
|
Academic Article
|
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.
|
Academic Article
|
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease.
|
Academic Article
|
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
|
Academic Article
|
Oxidative damage is the earliest event in Alzheimer disease.
|
Academic Article
|
Therapeutic potential in Alzheimer disease.
|
Academic Article
|
Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease.
|
Academic Article
|
Reactive oxygen: its sources and significance in Alzheimer disease.
|
Academic Article
|
Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits.
|
Academic Article
|
Possible protective mechanisms of heme oxygenase-1 in the brain.
|
Academic Article
|
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease.
|
Academic Article
|
Mitotic and gender parallels in Alzheimer disease: therapeutic opportunities.
|
Academic Article
|
Evidence for the role of gonadotropin hormones in the development of Alzheimer disease.
|
Academic Article
|
Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.
|
Academic Article
|
Brain and brawn: parallels in oxidative strength.
|
Academic Article
|
Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.
|
Academic Article
|
Causes of oxidative stress in Alzheimer disease.
|
Academic Article
|
Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology.
|
Academic Article
|
Oxidative stress signaling in Alzheimer's disease.
|
Academic Article
|
Neuronal binucleation in Alzheimer disease hippocampus.
|
Academic Article
|
Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases.
|
Academic Article
|
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
|
Academic Article
|
Prospects on the origin of Alzheimer's disease.
|
Academic Article
|
Elastase is associated with the neurofibrillary pathology of Alzheimer disease: a putative link between proteolytic imbalance and oxidative stress.
|
Academic Article
|
A novel perspective on tau in Alzheimer's disease.
|
Academic Article
|
Imaging the Alzheimer brain.
|
Academic Article
|
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
|
Academic Article
|
Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
|
Academic Article
|
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.
|
Academic Article
|
Ra?l Mena: 1953-2014.
|
Academic Article
|
Alternative neural circuitry that might be impaired in the development of Alzheimer disease.
|
Academic Article
|
Two hundred treasured issues!
|
Academic Article
|
Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer's disease.
|
Academic Article
|
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
|
Academic Article
|
BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways.
|
Academic Article
|
Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer's Disease.
|
Academic Article
|
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective.
|
Academic Article
|
Alzheimer's Disease Patients in the Crosshairs of COVID-19.
|
Award or Honor Receipt
|
Top 20 Most-Cited Authors in Alzheimer’s Disease
|
Award or Honor Receipt
|
Top 100 Alzheimer’s Disease Investigators
|
Award or Honor Receipt
|
Alzheimer Award / Alzheimer Medal
|
Award or Honor Receipt
|
Alzheimer Award / Alzheimer Medal
|
Award or Honor Receipt
|
Top 20 Alzheimer’s Disease Authors
|
Award or Honor Receipt
|
Leading Expert-Alzheimer Disease
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
Grant
|
NEUROFIBRILLARY PATHOLOGY IN ALZHEIMER DISEASE
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
Academic Article
|
Ethanol-Fixed, Paraffin-Embedded Tissue Imaging: Implications for Alzheimer's Disease Research.
|
Academic Article
|
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
|
Academic Article
|
Hippocampal Unicellular Recordings and Hippocampal-dependent Innate Behaviors in an Adolescent Mouse Model of Alzheimer's disease.
|
Academic Article
|
Strawberry (Fragaria ananassa duch.) Alba extract attenuates DNA damage in lymphocytes of patients with Alzheimer's disease.
|
Academic Article
|
Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease".
|
Academic Article
|
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
|
Academic Article
|
RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
|
Academic Article
|
A Multilevel View of the Development of Alzheimer's Disease.
|
Academic Article
|
Toll-like receptors in Alzheimer's disease.
|
Academic Article
|
Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review.
|
Academic Article
|
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization.
|
Academic Article
|
Optogenetics: implications for Alzheimer's disease research and therapy.
|
Academic Article
|
Making the Case for Accelerated Withdrawal of Aducanumab.
|
Academic Article
|
Lessons from antiamyloid-? immunotherapies in Alzheimer's disease.
|
Academic Article
|
Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease.
|
Academic Article
|
SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
|
Academic Article
|
Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria.
|
Academic Article
|
The Amyloid-? Pathway in Alzheimer's Disease.
|
Academic Article
|
Synthesize heterogeneous biological knowledge via representation learning for Alzheimer's disease drug repurposing.
|
Academic Article
|
Alzheimer's Disease: Not Just for the Aged?
|
Academic Article
|
Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia.
|
Academic Article
|
Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement.
|
Academic Article
|
Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?
|
Academic Article
|
Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
|
Academic Article
|
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
|
Academic Article
|
MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment.
|
Academic Article
|
Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer's disease brain.
|
Academic Article
|
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls.
|
Academic Article
|
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration.
|
Academic Article
|
Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
|
Academic Article
|
The amyloid-? pathway in Alzheimer's disease: a plain language summary.
|
Academic Article
|
Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease.
|
Academic Article
|
MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?
|
Academic Article
|
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
|
Academic Article
|
Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
|
Academic Article
|
Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on a-Synuclein and Tau Aggregation.
|